TrademarkDir
M.V.C. 9+3
DEAD

Serial Number

73438949

Owner

LYPHOMED, INC.

Attorney

Myron C. Cass

First Use Date

Nov 30, 1981

Filing Date

Aug 12, 1983

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

M.V.C. 9+3 Trademark

Serial Number: 73438949 • Registration: 1306775

M.V.C. 9+3 is a trademark filed by LYPHOMED, INC. on August 12, 1983. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

LYPHOMED, INC. (29 trademarks)

MELROSE PARK, IL 60160

Entity Type: 03

Trademark Details

Filing Date

August 12, 1983

Registration Date

November 27, 1984

First Use Anywhere

November 30, 1981

First Use in Commerce

November 30, 1981

Published for Opposition

September 18, 1984

Cancellation Date

September 3, 2005

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 3, 2005 CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 3, 2005 CAEX
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 6, 1990 C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 6, 1990 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Feb 23, 1990 815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Feb 23, 1990 815F
REGISTERED-PRINCIPAL REGISTER
Nov 27, 1984 R.PR
REGISTERED-PRINCIPAL REGISTER
Nov 27, 1984 R.PR
PUBLISHED FOR OPPOSITION
Sep 18, 1984 PUBO
PUBLISHED FOR OPPOSITION
Sep 18, 1984 PUBO
NOTICE OF PUBLICATION
Jul 18, 1984 NPUB
NOTICE OF PUBLICATION
Jul 18, 1984 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 1984 CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 1984 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 1984 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 1984 CRFA
NON-FINAL ACTION MAILED
Apr 5, 1984 CNRT
NON-FINAL ACTION MAILED
Apr 5, 1984 CNRT
ASSIGNED TO EXAMINER
Mar 6, 1984 DOCK
ASSIGNED TO EXAMINER
Mar 6, 1984 DOCK
ASSIGNED TO EXAMINER
Feb 27, 1984 DOCK
ASSIGNED TO EXAMINER
Feb 27, 1984 DOCK

Related Trademarks

More from this Owner

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

IPHARM

IPHARM

IPHARM

IPHARM

IPHARM

IPHARM